Friday's Underperforming Sectors: General Contractors & Builders, Healthcare Providers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Source: NASDAQ.COM
Market Performance: Hospital and medical practitioners' shares are lagging the market, down approximately 0.2% overall.
Key Contributors: Ardent Health and Agilon Health are leading the decline, with shares down 2.8% and 1.8%, respectively.
Sector Laggards: The report also mentions general contractors and builders as part of the sector laggards on the same day.
Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AGL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AGL
Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is 0.98 USD with a low forecast of 0.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
1 Buy
7 Hold
2 Sell
Hold
Current: 0.821
Low
0.50
Averages
0.98
High
1.50
Current: 0.821
Low
0.50
Averages
0.98
High
1.50
About AGL
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Agilon Health Faces Class Action Lawsuit Notification
- Class Action Initiation: Levi & Korsinsky LLP has notified investors that Agilon Health, Inc. (NYSE: AGL) is facing a class action lawsuit for alleged securities fraud, with the lawsuit covering the period from February 26, 2025, to August 4, 2025, aimed at recovering losses for affected investors.
- False Statement Allegations: The complaint alleges that the defendants recklessly issued guidance for 2025 despite being aware of significant industry headwinds, and materially overstated the positive financial impact of 'strategic actions' taken by Agilon, resulting in misleading statements about the company's business and prospects.
- Investor Rights Protection: Affected investors have until March 2, 2026, to apply to be appointed as lead plaintiff to share in any recovery, with no out-of-pocket costs or fees required to participate, thereby lowering the barrier for investor involvement in the lawsuit.
- Law Firm Background: Levi & Korsinsky has over 20 years of experience in securities litigation, having secured hundreds of millions for aggrieved shareholders, and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years, demonstrating its expertise in complex securities cases.
Continue Reading
Faruqi & Faruqi Investigates Securities Fraud at agilon health
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud claims against agilon health, focusing on investor losses incurred between February 26 and August 4, 2025, indicating significant legal risks for the company.
- Financial Guidance Missteps: The lawsuit alleges that agilon health executives recklessly issued guidance for 2025 that they knew was unattainable due to known industry headwinds, resulting in substantial investor losses and highlighting governance failures within the company.
- Stock Price Plunge: Following the announcement to suspend its 2025 financial guidance, agilon health's stock plummeted by 51.5% on August 5, 2025, reflecting severe market concerns regarding the company's financial health.
- Investor Rights Protection: Faruq & Faruqi encourages investors to be aware that March 2 is the deadline to apply as lead plaintiff in the class action, emphasizing the importance of protecting investor rights.
Continue Reading